Instituto Sanidad Ganadera, Argentina acquired by Ceva >
New company will build on strong biological expertise and expand Ceva’s platform in South American zone.
Joint Venture agreement between Ceva and Huadu signed in Beijing >
“Ceva Huadu” to become Innovation & R&D platform for biologicals
Dr. Steve Chu joins Ceva after 25 years at Fort Dodge and Elanco >
Addition to talented team positions Ceva for continued growth.
Ceva opens new production facility in Lenexa, Kansas >
May 3, 2011, Lenexa, Kan. –– Ceva Animal Health is pleased to announce the May 3, 2011 opening of a new poultry vaccine production facility at its Biomune Campus in Lenexa, Kansas.
Ceva re-enforces expertise in freeze-drying with completion of € 2.8m plant >
Ceva Santé Animale intends to use the new freeze-drying facility to increase its toll-manufacturing activity.
Ceva conducts latest of its Expert Symposia >
Veterinary specialists gather in Madrid to discuss latest trends in sow reproduction
Ceva termine sa première décennie de réussite sur une forte croissance >
Les résultats de 2010 démontrent une capacité globale à générer des ventes et des bénéfices
Ceva finishes first decade of success with strong growth >
2010 results demonstrate global ability to generate sales and earnings
Ceva launches latest of its Vector Vaccines at VIV Asia 2011 >
VECTORMUNE HVT- NDV® generates strong interest at symposium organised to present new strategies to combat Newcastle Disease.
Ceva becomes official partner of Vet2011 >
2011 is World Veterinary year, let’s show pride in our profession “Vet for health, Vet for food, Vet for the planet!”.